Bozkurt Biykem, Khalaf Shaden
WINTERS CENTER FOR HEART FAILURE RESEARCH, CARDIOVASCULAR RESEARCH INSTITUTE, BAYLOR COLLEGE OF MEDICINE, HOUSTON, TEXAS.
Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):216-223. doi: 10.14797/mdcj-13-4-216.
Heart failure is an important cause of morbidity and mortality in women, and they tend to develop it at an older age compared to men. Heart failure with preserved ejection fraction is more common in women than in men and accounts for at least half the cases of heart failure in women. When comparing men and women who have heart failure and a low left ventricular ejection fraction, the women are more symptomatic and have a similarly poor outcome. Overall recommendations for guideline-directed medical therapies show no differences in treatment approaches between men and women. Overall, women are generally underrepresented in clinical trials for heart failure. Further studies are needed to shed light into different mechanisms, causes, and targeted therapies of heart failure in women.
心力衰竭是女性发病和死亡的重要原因,与男性相比,她们往往在年龄较大时患上心力衰竭。射血分数保留的心力衰竭在女性中比男性更常见,至少占女性心力衰竭病例的一半。在比较患有心力衰竭且左心室射血分数低的男性和女性时,女性症状更明显,预后同样较差。针对指南指导的药物治疗的总体建议显示,男性和女性的治疗方法没有差异。总体而言,女性在心力衰竭临床试验中的代表性普遍不足。需要进一步研究以阐明女性心力衰竭的不同机制、病因和靶向治疗方法。